• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分期双侧手术治疗同步性多原发性肺癌的预后因素的识别。

Identification of the Prognostic Factors for Synchronous Multiple Primary Lung Cancer Treated With Staged Bilateral Surgery.

机构信息

Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Department of Oncology, Dongying People's Hospital, Dongying, Shandong, China.

出版信息

Clin Respir J. 2024 Oct;18(10):e70017. doi: 10.1111/crj.70017.

DOI:10.1111/crj.70017
PMID:39396926
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11471348/
Abstract

INTRODUCTION

Staged bilateral surgery is widely used to treat synchronous multiple primary lung cancer (SMPLC); however, the prognostic factors for survival outcomes remain unclear. This study aimed to identify prognostic factors and construct a predictive model for overall survival (OS) and recurrence-free survival (RFS) in patients with SMPLC who underwent staged bilateral surgery.

METHODS

The study included 256 patients diagnosed with SMPLC and treated with staged bilateral surgery at our hospital between January 2010 and July 2017. Multivariate Cox proportional-hazard regression was used to identify prognostic factors for OS and RFS. Additionally, a predictive model was constructed using time-dependent receiver operating characteristic curves.

RESULTS

Among the 256 patients, 10 (3.95%) succumbed to the disease and 24 (9.41%) experienced recurrence. Smoking (hazard ratio [HR]: 5.128; 95% confidence interval [CI]: 1.442-18.233; p = 0.012) and most advanced pathological TNM (pTNM) stage (II + III) (HR: 12.938; 95% CI: 2.650-63.176; p = 0.002) were identified as significant predictors of poor OS. A prognostic model was developed for predicting OS, with a 5-year area under the curve (AUC) of 0.854. Furthermore, most advanced pTNM stage (II + III) was associated with poor RFS (HR: 5.964; 95% CI: 2.669-13.327; p < 0.001), and the predictive model exhibited a 5-year AUC of 0.718 for RFS.

CONCLUSION

This study revealed that smoking and most advanced pTNM stage were independent prognostic factors associated with poor OS in patients with bilateral SMPLC. Moreover, most advanced pTNM stage was also linked to unfavorable RFS. The developed predictive model demonstrated moderate prognostic performance for both OS and RFS.

摘要

简介

分期双侧手术广泛用于治疗同步多原发性肺癌(SMPLC);然而,生存结果的预后因素仍不清楚。本研究旨在确定分期双侧手术治疗 SMPLC 患者的总生存(OS)和无复发生存(RFS)的预后因素,并构建预测模型。

方法

本研究纳入了 2010 年 1 月至 2017 年 7 月在我院接受分期双侧手术治疗的 256 例 SMPLC 患者。采用多变量 Cox 比例风险回归分析识别 OS 和 RFS 的预后因素。此外,使用时间依赖性接收器操作特征曲线构建预测模型。

结果

在 256 例患者中,有 10 例(3.95%)死于该疾病,24 例(9.41%)发生复发。吸烟(风险比[HR]:5.128;95%置信区间[CI]:1.442-18.233;p=0.012)和最晚期病理 TNM(pTNM)分期(II+III)(HR:12.938;95%CI:2.650-63.176;p=0.002)被确定为 OS 不良的显著预测因素。建立了一个预测 OS 的模型,其 5 年 AUC 为 0.854。此外,最晚期 pTNM 分期(II+III)与 RFS 不良相关(HR:5.964;95%CI:2.669-13.327;p<0.001),预测模型的 RFS 5 年 AUC 为 0.718。

结论

本研究表明,吸烟和最晚期 pTNM 分期是双侧 SMPLC 患者 OS 不良的独立预后因素。此外,最晚期 pTNM 分期与不利的 RFS 相关。所开发的预测模型对 OS 和 RFS 均具有中等的预后性能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fe4/11471348/c0c11c074de2/CRJ-18-e70017-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fe4/11471348/179bdaa981da/CRJ-18-e70017-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fe4/11471348/c0c11c074de2/CRJ-18-e70017-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fe4/11471348/179bdaa981da/CRJ-18-e70017-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fe4/11471348/c0c11c074de2/CRJ-18-e70017-g001.jpg

相似文献

1
Identification of the Prognostic Factors for Synchronous Multiple Primary Lung Cancer Treated With Staged Bilateral Surgery.分期双侧手术治疗同步性多原发性肺癌的预后因素的识别。
Clin Respir J. 2024 Oct;18(10):e70017. doi: 10.1111/crj.70017.
2
Surgical Prognosis of Synchronous Multiple Primary Lung Cancer: Systematic Review and Meta-Analysis.同步多原发性肺癌的外科预后:系统评价和荟萃分析。
Clin Lung Cancer. 2021 Jul;22(4):341-350.e3. doi: 10.1016/j.cllc.2020.10.022. Epub 2020 Nov 5.
3
Surgical results of synchronous multiple primary lung cancers: similar to the stage-matched solitary primary lung cancers?同步多原发性肺癌的手术治疗结果:与分期匹配的单发性原发性肺癌相似?
Ann Thorac Surg. 2013 Dec;96(6):1966-74. doi: 10.1016/j.athoracsur.2013.04.142. Epub 2013 Sep 7.
4
Nomograms for Predicting Overall and Recurrence-free Survival From Pathologic Stage IA and IB Lung Cancer After Lobectomy.肺癌根治术后 IA 和 IB 期患者总生存和无复发生存的预测列线图
Clin Lung Cancer. 2021 Jul;22(4):e574-e583. doi: 10.1016/j.cllc.2020.10.009. Epub 2020 Oct 22.
5
[Analysis on the Prognostic and Survival Factors of Synchronous Multiple Primary Lung Cancer].[同步性多原发性肺癌的预后及生存因素分析]
Zhongguo Fei Ai Za Zhi. 2017 Jan 20;20(1):21-27. doi: 10.3779/j.issn.1009-3419.2017.01.03.
6
Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.开发和评估一种临床计算器,用于估计接受化疗、放疗和手术治疗的局部晚期直肠癌患者的复发和生存可能性。
JAMA Netw Open. 2021 Nov 1;4(11):e2133457. doi: 10.1001/jamanetworkopen.2021.33457.
7
[Using Immunohistochemical Markers and Clinicopathological Factors to Predict the Prognostic Survival of Different Types of Endometrial Cancer Recurrence].[利用免疫组化标志物和临床病理因素预测不同类型子宫内膜癌复发的预后生存情况]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2021 May;52(3):489-496. doi: 10.12182/20210560205.
8
The prognostic value of Kirsten rat sarcoma viral oncogene homolog mutations in resected lung adenocarcinoma differs according to clinical features.KRAS 基因突变在肺腺癌中的预后价值因其临床特征而异。
J Thorac Cardiovasc Surg. 2022 Jan;163(1):e73-e85. doi: 10.1016/j.jtcvs.2020.05.097. Epub 2020 Jun 21.
9
Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.对比解剖性肺段切除术与肺叶切除术治疗临床ⅠA 期肺腺癌的肿瘤学结果:多中心研究中的倾向性评分匹配分析。
J Thorac Cardiovasc Surg. 2013 Aug;146(2):358-64. doi: 10.1016/j.jtcvs.2013.02.008. Epub 2013 Mar 8.
10
Survival in synchronous vs. single lung cancer: upstaging better reflects prognosis.同步性肺癌与单发肺癌的生存率:分期上调更能反映预后。
Chest. 2000 Oct;118(4):952-8. doi: 10.1378/chest.118.4.952.

本文引用的文献

1
A Novel Prognostic Score Based on Multiple Quantitative Parameters of Chest CT for Patients with Synchronous Multiple Primary Lung Cancer: Is Solid Component Size a Better Prognostic Indicator?基于胸部CT多个定量参数的同步性多原发性肺癌患者新型预后评分:实性成分大小是否为更好的预后指标?
Ann Surg Oncol. 2023 Jun;30(6):3769-3778. doi: 10.1245/s10434-023-13248-2. Epub 2023 Feb 23.
2
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
3
Synchronous Multiple Lung Cancers with Lymph Node Metastasis and Different EGFR Mutations: Intrapulmonary Metastasis or Multiple Primary Lung Cancers?
伴有淋巴结转移及不同表皮生长因子受体(EGFR)突变的同步性多原发性肺癌:肺内转移还是多原发性肺癌?
Onco Targets Ther. 2021 Feb 16;14:1093-1099. doi: 10.2147/OTT.S294953. eCollection 2021.
4
Characteristics and prognosis of synchronous multiple primary lung cancer after surgical treatment: A systematic review and meta-analysis of current evidence.手术治疗后同步多原发性肺癌的特征和预后:当前证据的系统回顾和荟萃分析。
Cancer Med. 2021 Jan;10(2):507-520. doi: 10.1002/cam4.3614. Epub 2020 Dec 10.
5
Surgical Prognosis of Synchronous Multiple Primary Lung Cancer: Systematic Review and Meta-Analysis.同步多原发性肺癌的外科预后:系统评价和荟萃分析。
Clin Lung Cancer. 2021 Jul;22(4):341-350.e3. doi: 10.1016/j.cllc.2020.10.022. Epub 2020 Nov 5.
6
Multiple primary lung cancer: a rising challenge.多发性原发性肺癌:一项日益严峻的挑战。
J Thorac Dis. 2019 Mar;11(Suppl 4):S523-S536. doi: 10.21037/jtd.2019.01.56.
7
Importance of Smoking Cessation on Surgical Outcome in Primary Lung Cancer.戒烟对原发性肺癌手术结果的重要性。
Ann Thorac Surg. 2019 Apr;107(4):1005-1009. doi: 10.1016/j.athoracsur.2018.12.002. Epub 2019 Jan 2.
8
The Value of Prognostic Factors for Survival in Synchronous Multifocal Lung Cancer: A Retrospective Analysis of 164 Patients.同步多原发肺癌生存预后因素的价值:164 例回顾性分析。
Ann Thorac Surg. 2018 Mar;105(3):930-936. doi: 10.1016/j.athoracsur.2017.09.035. Epub 2018 Feb 1.
9
Stage I synchronous multiple primary non-small cell lung cancer: CT findings and the effect of TNM staging with the 7th and 8th editions on prognosis.I期同步多发原发性非小细胞肺癌:CT表现及第七版和第八版TNM分期对预后的影响
J Thorac Dis. 2017 Dec;9(12):5335-5344. doi: 10.21037/jtd.2017.12.101.
10
Influence of Ground Glass Opacity and the Corresponding Pathological Findings on Survival in Patients with Clinical Stage I Non-Small Cell Lung Cancer.临床Ⅰ期非小细胞肺癌患者磨玻璃密度影及其相应的病理结果对生存的影响。
J Thorac Oncol. 2018 Apr;13(4):533-542. doi: 10.1016/j.jtho.2017.11.129. Epub 2017 Dec 13.